Effects of varying base-case estimates on the incremental cost–effectiveness ratio of treating all patients with advanced renal insufficiency with an ACE inhibitor versus no ACE inhibitor ...

Routine use of angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) is recommended in proteinuric nontransplant kidney disease patients, to reduce proteinuria and ...

effectively decreases rates of urinary protein excretion and slows progression of proteinuric renal disease. Some studies have indicated that concomitant administration of an ACE inhibitor and an ...

Hypertension is typically treated with medications like diuretics, ACE inhibitors, beta-blockers, calcium channel blockers, ...

The message is that an early decrease in eGFR with finerenone should not lead to stopping the medication, say HF experts.

Diuretics on their own are often not enough to treat hypertension precipitated from renal artery stenosis, and they are ...

A recent study from Columbia University has raised important questions about the medications used to treat high blood ...

ACE inhibitors have also been shown to protect and improve heart pumping function in patients with heart failure. They have also been shown to protect kidney function, particularly in patients ...

Adjust antidiabetic, antigout medications. Hyperkalemia more likely with ACE inhibitors. NSAIDs may cause renal failure. Hypokalemia with corticosteroids, ACTH, amphotericin B. Hypotension with ...

May antagonize ACE inhibitors, β-blockers, diuretics, uricosurics. Increased bleeding risk with NSAIDs or chronic, heavy alcohol use. NSAIDs increase risk of renal dysfunction. To reduce combined ...

Objective: To determine the cost–effectiveness of ACE inhibitor therapy in nondiabetic proteinuric patients with advanced renal disease in Germany. Methods: Two strategies were compared ...